Clinical significance of serum vascular cell adhesion molecule-1 levels in patients with hepatocellular carcinoma.
about
Recent developments in the first detection of hepatocellular carcinomaPhase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinomaActivation of AMP-activated protein kinase attenuates hepatocellular carcinoma cell adhesion stimulated by adipokine resistin.Significance of TNF-α and the Adhesion Molecules: L-Selectin and VCAM-1 in Papillary Thyroid Carcinoma.Effects of thalidomide on the expression of adhesion molecules in rat liver cirrhosis.A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma.
P2860
Clinical significance of serum vascular cell adhesion molecule-1 levels in patients with hepatocellular carcinoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Clinical significance of serum ...... with hepatocellular carcinoma.
@ast
Clinical significance of serum ...... with hepatocellular carcinoma.
@en
type
label
Clinical significance of serum ...... with hepatocellular carcinoma.
@ast
Clinical significance of serum ...... with hepatocellular carcinoma.
@en
prefLabel
Clinical significance of serum ...... with hepatocellular carcinoma.
@ast
Clinical significance of serum ...... with hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Clinical significance of serum ...... with hepatocellular carcinoma.
@en
P2093
Cindy-S Tong
Joanna-W Ho
Ronnie-T Poon
Sheung-Tat Fan
P2860
P304
P356
10.3748/WJG.V10.I14.2014
P407
P577
2004-07-01T00:00:00Z